Mahindra & Mahindra, Titan and Infosys to see some action today

Titan Company Ltd. | Diamond & Jewellery | Consumer Durables | BSE: 500114 | NSE: TITAN

12 Apr 2021 Evaluate

Mahindra & Mahindra (M&M) is planning to put fresh investments to the tune of Rs 3000 crore on its Electric Vehicles (EV) business in the next three years, while it looks for more alliances and partnerships in the vertical. The company is working on developing on an EV platform by combining capabilities of its operations across the globe, including Detroit and Italy.

Titan Company’s subsidiary company -- Tanishq has unveiled a new brand proposition for its wedding exclusive sub-brand 'Rivaah' - Jewel for every tradition. The new proposition from Rivaah by Tanishq communicates the meaning and significance of every ritual and jewellery the bride wears. Even as there is a general nervousness in the gems and jewellery industry about the Covid related restrictions in Maharashtra impacting the wedding season demand, Tanishq is betting big on the rest of the markets for the wedding jewellery.

Infosys’ Board of Directors is going to consider on proposal for buyback of fully paid-up equity shares of the company. The outcome of the Board meeting will be disseminated to the stock exchanges after conclusion of the Board meeting on April 14, 2021, in accordance with the applicable provisions of the SEBI LODR Regulations.

Castrol India and Ki Mobility Solutions have entered into an exclusive supply arrangement in India wherein Castrol shall supply lubricant products to Ki Mobility's multi-brand workshops.

Century Plyboards (India) has introduced a pioneering solution for its customers by launching the use of Firewall Technology in manufacturing its products. Firewall technology ensures that its customers get critical time to act and be safe in case of fire. Firewall Technology is the outcome of arduous and indigenous research work done by the organization.

Natco Pharma’s marketing and distribution partner -- Alvogen Pine Brook LLC, has received tentative approval for Abbreviated New Drug Application (ANDA) Ibrutinib Tablets 560mg, 420mg, 280mg and 140mg strengths (generic for Imbruvica), from the U.S. Food and Drug Administration (USFDA).

Transwarranty Finance has raised Rs 25 lakh through Secured Redeemable Non Convertible Debentures (NCDs) under Thirteenth Tranche/Series M/2020-21, on private placement basis.